VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.18
Tradestie Score
51
Market Cap
$108.92M
Revenue Growth
5.0%
Analyst Upside
+456.5%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.05
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 48 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 49 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.15
|
$67.94M | - | 58 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$25.55
|
$62.81M | - | 43 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$0.52
|
$46.20M | - | 54 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$1.72
|
$34.77M | - | 49 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$1.72
|
$4.78M | - | 40 | Compare |
More VTGN Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry